Genetic engineering may hold key to Lyme disease vaccine

04/6/2010 | USA Today

Researchers found that deactivating one gene in the tick-borne bacteria that cause Lyme disease helped prevent mice from contracting the disease. The hope is that the research by Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention in Fort Collins, Colo., holds the key to a human vaccine.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN